Literature DB >> 5090242

Albumin metabolism in rheumatoid arthritis.

F C Ballantyne, A Fleck, W C Dick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5090242      PMCID: PMC1005765          DOI: 10.1136/ard.30.3.265

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

1.  A SIMPLE METHOD OF SERUM PROTEIN FRACTIONATION ON CELLULOSE ACETATE AND A COMPARISON OF THE ALBUMIN LEVELS WITH A METHOD OF SODIUM SULPHITE FRACTIONATION.

Authors:  D WEBSTER
Journal:  Clin Chim Acta       Date:  1965-02       Impact factor: 3.786

2.  THE MECHANISM OF HYPOALBUMINEMIA IN RHEUMATOID ARTHRITIS.

Authors:  P WILKINSON; R JEREMY; F P BROOKS; J L HOLLANDER
Journal:  Ann Intern Med       Date:  1965-07       Impact factor: 25.391

3.  Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men.

Authors:  Y TAKEDA; E B REEVE
Journal:  J Lab Clin Med       Date:  1963-02

4.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

5.  The effects of adrenocortical hormones on albumin metabolism studied with albumin-I 131.

Authors:  M A ROTHSCHILD; S S SCHREIBER; M ORATZ; H L McGEE
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808

6.  Behaviour of 14C- and 131I-labelled plasma proteins in the rat.

Authors:  R M CAMPBELL; D P CUTHBERTSON; C M MATTHEWS; A S MCFARLANE
Journal:  Int J Appl Radiat Isot       Date:  1956-07

7.  Measurement of joint inflammation. A radioisotopic method.

Authors:  W C Dick; R R Neufeld; A G Prentice; A Woodburn; K Whaley; G Nuki; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1970-03       Impact factor: 19.103

8.  Albumin and gamma-globulin tracer studies in protein depletion states.

Authors:  R Hoffenberg; E Black; J F Brock
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

9.  Prediction of lean body mass from height and weight.

Authors:  R Hume
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

10.  Difference in daily albumin synthesis between normal men and women as measured with II31-labeled albumin.

Authors:  J L STEINFELD
Journal:  J Lab Clin Med       Date:  1960-06
View more
  19 in total

1.  Serum sulphydryl changes in rheumatoid coalworkers' pneumoconiosis patients treated with D-penicillamine.

Authors:  P H Evans
Journal:  Proc R Soc Med       Date:  1977

2.  Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis.

Authors:  M Farr; M J Kendall; D W Young; M J Meynell; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

Review 3.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

4.  Hypoalbuminaemia and naproxen pharmacokinetics in a patient with rheumatoid arthritis.

Authors:  F A Van den Ouweland; F W Gribnau; Y Tan; C A Van Ginneken; L B Van de Putte
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

5.  Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction.

Authors:  J Webb; K Whaley; R N MacSween; G Nuki; W C Dick; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

6.  Effect of auranofin on plasma fibronectin, C reactive protein, and albumin levels in arthritic rats.

Authors:  K M Connolly; V J Stecher; D J Pruden
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

7.  Delayed cutaneous hypersensitivity in rheumatoid arthritis: the influence of nutrition and drug therapy.

Authors:  M G Helliwell; G S Panayi; A Unger
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

8.  [Methotrexate in rheumatology].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

9.  Auranofin. New oral gold compound for treatment of rheumatoid arthritis.

Authors:  A E Finkelstein; D T Walz; V Batista; M Mizraji; F Roisman; A Misher
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

Review 10.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.